PROK
NASDAQ · Biotechnology
Prokidney Corp
$1.90
+0.02 (+1.06%)
Analyst Consensus
Buy
15
Analysts
High
Coverage
Price Target
Analyst Price Target
+943.2% upside
Low Target
$13.43
Average Target
$19.82
High Target
$25.07
Current Price
$1.90
Current
$1.90
$1.90
Target
$19.82
$19.82
$13.43
$19.82 avg
$25.07
Scenario Analysis
Bear Case
$13.43
606.8%
Low target
Base Case
$19.82
+943.2%
Avg target
Bull Case
$25.07
+1,219.5%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$7.13
-73.4% from high
52-Week Low
$0.54
+251.9% from low
Target vs 52W High
$19.82
+178.0% vs high
Next Earnings Report
May 11, 2026
Today
EPS Est: $-0.14
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 40 | 75% | $257.58 | +27.8% |
| AMGN | Hold | 44 | 48% | $190.87 | -42.5% |
| GILD | Strong Buy | 39 | 79% | $362.68 | +176.2% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | +2.0% |
| REGN | Strong Buy | 38 | 79% | $76.80 | -89.3% |
| ALNY | Strong Buy | 36 | 75% | $102.31 | -65.3% |
| RVMD | Strong Buy | 27 | 96% | $114.11 | -19.5% |
| INSM | Strong Buy | 28 | 96% | $143.40 | +41.5% |